Home/Filings/4/0000899243-17-023126
4//SEC Filing

Brightstar Associates LLC 4

Accession 0000899243-17-023126

CIK 0001654151other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:31 PM ET

Size

13.7 KB

Accession

0000899243-17-023126

Insider Transaction Report

Form 4
Period: 2017-10-02
Transactions
  • Conversion

    Series B Preferred Stock

    2017-10-02297,0300 total
    Common Stock (1,678,219 underlying)
  • Conversion

    Common Stock

    2017-10-02+16,572,37016,572,370 total
  • Conversion

    Series A Preferred Stock

    2017-10-021,976,1340 total
    Common Stock (11,165,157 underlying)
  • Conversion

    Series C Preferred Stock

    2017-10-02263,9910 total
    Common Stock (1,491,549 underlying)
  • Conversion

    Series B-1 Preferred Stock

    2017-10-02396,0080 total
    Common Stock (2,237,445 underlying)
Footnotes (1)
  • [F1]Represents preferred stock of Deciphera Pharmaceuticals, LLC. Upon the closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into 5.65 shares of common stock of the Issuer.

Issuer

Deciphera Pharmaceuticals, Inc.

CIK 0001654151

Entity typeother
IncorporatedMO

Related Parties

1
  • filerCIK 0001717503

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:31 PM ET
Size
13.7 KB